Publications by authors named "Walid Chemlali"

Claim this Profile
R
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
Florence Coussy, Marion Lavigne, Leanne de Koning, Rania El Botty, Fariba Nemati, Walid Chemlali

Theranostics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Céline Callens, Keltouma Driouch, Anaïs Boulai, Zakia Tariq, Aurélie Comte, Walid Chemlali

Genome Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Instability Signature of Palindromic Non-Coding Somatic Mutations in Bladder Cancer.
Sophie Vacher, Voreak Suybeng, Elodie Girard, Julien Masliah Planchon, Grégory Thomson, Walid Chemlali

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biopathological Significance of PIWI-piRNA Pathway Deregulation in Invasive Breast Carcinomas.
Didier Meseure, Sophie Vacher, Sabah Boudjemaa, Marick Laé, André Nicolas, Walid Chemlali

Cancers (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance.
Elodie Montaudon, Joanna Nikitorowicz-Buniak, Laura Sourd, Ludivine Morisset, Rania El Botty, Walid Chemlali

Nat Commun· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune gene expression in head and neck squamous cell carcinoma patients.
Charlotte Lecerf, Maud Kamal, Sophie Vacher, Walid Chemlali, Anne Schnitzler

Eur J Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Positive Correlations between and -/-/- Gene Cluster Overexpression in Multi-Tumor Types Suggest Deregulated Activation of an Bidirectional Promoter.
Kinan Drak Alsibai, Sophie Vacher, Didier Meseure, Andre Nicolas, Marick Lae, Walid Chemlali

Noncoding RNA· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential gene expression in growth factors, epithelial mesenchymal transition and chemotaxis in the diffuse type compared with the intestinal type of gastric cancer.
Martine Perrot-Applanat, Sophie Vacher, Cynthia Pimpie, Walid Chemlali, Simon Derieux

Oncol Lett· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer.
Edith Borcoman, Philippe De La Rochere, Wilfrid Richer, Sophie Vacher, Walid Chemlali

Oncoimmunology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Prevalence of a Hotspot of Noncoding Somatic Mutations in Intron 6 of in Bladder Cancer.
Simon Garinet, Géraldine Pignot, Sophie Vacher, Constance Le Goux, Anne Schnitzler, Walid Chemlali

Mol Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of the deglutamylase CCP5 perturbs multiple steps of spermatogenesis and leads to male infertility.
Tiziana Giordano, Sudarshan Gadadhar, Satish Bodakuntla, Jonas Straub, Sophie Leboucher, Walid Chemlali

J Cell Sci· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
Luc Cabel, Emmanuelle Jeannot, Ivan Bieche, Sophie Vacher, Celine Callens, Walid Chemlali

Clin Cancer Res· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Xu Liang, Adrien Briaux, Véronique Becette, Camille Benoist, Anais Boulai, Walid Chemlali

J Hematol Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.
Anne-Laure Renault, Noura Mebirouk, Laetitia Fuhrmann, Guillaume Bataillon, Eve Cavaciuti, Walid Chemlali

Breast Cancer Res· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
Sophie Vacher, Patrice Castagnet, Walid Chemlali, François Lallemand, Didier Meseure

PLoS One· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of the FOXO6 transcriptional factor in breast carcinogenesis.
François Lallemand, Ambre Petitalot, Sophie Vacher, Leanne de Koning, Karim Taouis, Walid Chemlali

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Embryonic signature distinguishes pediatric and adult rhabdoid tumors from other SMARCB1-deficient cancers.
Wilfrid Richer, Julien Masliah-Planchon, Nathalie Clement, Irene Jimenez, Laetitia Maillot, Walid Chemlali

Oncotarget· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways.
Marick Laé, Sophie Gardrat, Sophie Rondeau, Camille Richardot, Martial Caly, Walid Chemlali

Oncotarget· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.
Gabrielle Deniziaut, Jean Christophe Tille, François-Clément Bidard, Sophie Vacher, Anne Schnitzler, Walid Chemlali

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value.
Didier Meseure, Sophie Vacher, Kinan Drak Alsibai, Andre Nicolas, Walid Chemlali

Mol Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas.
Marie-Paule Sablin, Coraline Dubot, Jerzy Klijanienko, Sophie Vacher, Lamia Ouafi, Walid Chemlali

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer.
Didier Meseure, Sophie Vacher, François Lallemand, Kinan Drak Alsibai, Rana Hatem, Walid Chemlali

Br J Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis